A panel of experts discuss the treatment landscape of upper GI cancer, as well as unmet needs in GI, gastric, gastroesophageal junction, and esophageal cancers.
EP. 8: The Evolving Treatment Landscape of Upper GI and Esophageal CancerNovember 14th 2022
Laura Bobolts, PharmD, BCOP, and James M. Cleary, MD, PhD, explore the evolution of treatment for patients with upper GI and esophageal cancer, including first- and second-line treatment strategies for gastroesophageal cancer.
EP. 12: Decision-Making Within a Rapidly Evolving Field Where Labeling May Differ From Current Clinical GuidelinesNovember 28th 2022
Laura Bobolts, PharmD, BCOP, and James M. Cleary, MD, provide insights regarding gastroesophageal treatment decisions when FDA labels don’t reflect clinical practice guidelines.
EP. 14: Selecting Optimal Gastroesophageal Treatment: Chemotherapy, Immunotherapy, and Combined TherapiesDecember 5th 2022
James M. Cleary, MD, PhD, discusses chemotherapy and immunotherapy as appropriate individual strategies, as well as a combination therapy approach for patients with gastroesophageal cancer.